Explore facts and recommendations for pharmacological treatments for rare renal disorders.
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
PHYOX Clinical Development Program
An overview of the PHYOX clinical development program evaluating nedosiran for the treatment of primary hyperoxaluria.
This infographic provides an overview of PHYOX2, the pivotal randomized study of nedosiran in PH1 or PH2